Ironwood Pharma to acquire Swiss-based VectivBio in 1 bln deal
VECTDelisted Stock | USD 16.85 0.00 0.00% |
Slightly above 56% of VectivBio Holding's investor base is looking to short. The analysis of current outlook of investing in VectivBio Holding AG suggests that many traders are alarmed regarding VectivBio Holding's prospects. VectivBio Holding's investing sentiment can be driven by a variety of factors including economic data, VectivBio Holding's earnings reports, geopolitical events, and overall market trends.
VectivBio |
Ironwood Pharmaceuticals Inc said on Monday it will acquire Switzerland-based drug developer VectivBio Holding AG for 1.15 billion to boost its portfolio of experimental digestive disorder drugs.
Read at reuters.com
VectivBio Holding Fundamental Analysis
We analyze VectivBio Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
VectivBio Holding is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
VectivBio Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VectivBio Holding stock to make a market-neutral strategy. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics with similar companies.
Peers
VectivBio Holding Related Equities
ZURA | Zura Bio | 4.39 | ||||
ZVSA | ZyVersa Therapeutics | 2.63 | ||||
HEPA | Hepion Pharmaceuticals | 2.04 | ||||
IMMX | Immix Biopharma | 0.46 | ||||
CNSP | Cns Pharmaceuticals | 0.91 | ||||
ELEV | Elevation Oncology | 1.12 | ||||
OCEA | Ocean Biomedical | 3.02 | ||||
ENVB | Enveric Biosciences | 6.06 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |